ReviewLaryngoscope investigative otolaryngology2025
A Systematic Review of Case Reports of Spontaneous Retropharyngeal Hematoma.
Review in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Spontaneous retropharyngeal hematoma (SRH) is a rare and potentially life-threatening condition with the potential to cause acute airway obstruction. This review aims to describe the presentation, predisposing factors, and management of SRH cases to better understand the clinical course and guide strategies for identifying and managing this condition. Data Sources: PubMed, Embase, and Web of Science. Review Methods: Databases were queried for articles from inception to February 2025. Study protocols adhered to the PRISMA guidelines. Case reports and series describing SRH were included. Study validity was assessed using the Joanna Briggs institute's critical appraisal tools and AMSTAR 2 criteria. Results: Seventeen cases (eight males and nine females) met inclusion criteria for analysis. On average, they presented at 59.7 (± 21.4) years old with sudden dysphagia (76.5%), anterior neck swelling (64.7%), neck pain (58.8%), and dysphonia (41.2%). Notably, 4 (23.5%) patients were taking an antithrombotic medication. Diagnosis was made using CT neck in 82.4% of cases. While 12 (70.6%) cases were managed medically, 5 (29.4%) received surgical intervention, and 6 (35.3%) required intubation. 16 (94.1%) cases had complete resolution within an average of 27.9 (± 24.8) days, and one patient (5.9%) died from airway compromise. Conclusions: SRH is a rare condition that presents with nonspecific dysphagia or neck discomfort. Antithrombotic medications may serve as a risk factor. Most patients will not require operative management, but close observation is needed as progression to fatal airway compromise has been documented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.